BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12653561)

  • 21. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain.
    Gouri BS; Swarup G
    Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
    Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
    J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
    Delfino FJ; Stevenson H; Smithgall TE
    J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn.
    Kanda S; Mochizuki Y; Nakamura T; Miyata Y; Matsuyama T; Kanetake H
    J Cell Sci; 2005 Mar; 118(Pt 5):961-70. PubMed ID: 15713745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
    Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
    J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of c-Fes in normal and neoplastic hematopoiesis.
    Yates KE; Gasson JC
    Stem Cells; 1996 Jan; 14(1):117-23. PubMed ID: 8820957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and structural analysis of murine c-fes cDNA clones.
    Wilks AF; Kurban RR
    Oncogene; 1988 Sep; 3(3):289-94. PubMed ID: 3060793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An identity crisis for fps/fes: oncogene or tumor suppressor?
    Sangrar W; Zirgnibl RA; Gao Y; Muller WJ; Jia Z; Greer PA
    Cancer Res; 2005 May; 65(9):3518-22. PubMed ID: 15867340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.
    Shaffer JM; Hellwig S; Smithgall TE
    Biochemistry; 2009 Jun; 48(22):4780-8. PubMed ID: 19382747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence-based cloning of a protein tyrosine kinase with a yeast tribrid system.
    Clark DD; Peterson BR
    Chembiochem; 2005 Aug; 6(8):1442-8. PubMed ID: 16003805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The c-Fes family of protein-tyrosine kinases.
    Smithgall TE; Rogers JA; Peters KL; Li J; Briggs SD; Lionberger JM; Cheng H; Shibata A; Scholtz B; Schreiner S; Dunham N
    Crit Rev Oncog; 1998; 9(1):43-62. PubMed ID: 9754447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of conserved motifs in a bacterial tyrosine kinase, BtkB, from Myxococcus xanthus.
    Kato T; Shirakawa Y; Takegawa K; Kimura Y
    J Biochem; 2015 Nov; 158(5):385-92. PubMed ID: 25998248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human c-FES is a nuclear tyrosine kinase.
    Yates KE; Lynch MR; Wong SG; Slamon DJ; Gasson JC
    Oncogene; 1995 Mar; 10(6):1239-42. PubMed ID: 7700650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.